Your browser doesn't support javascript.
loading
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing.
Garcia-Cremades, Maria; Solans, Belen P; Hughes, Emma; Ernest, Jacqueline P; Wallender, Erika; Aweeka, Francesca; Luetkemeyer, Anne F; Savic, Radojka M.
Afiliación
  • Garcia-Cremades M; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Solans BP; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Hughes E; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Ernest JP; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
  • Wallender E; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Aweeka F; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Luetkemeyer AF; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
Clin Pharmacol Ther ; 108(2): 253-263, 2020 08.
Article en En | MEDLINE | ID: mdl-32285930
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Betacoronavirus / Hidroxicloroquina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Betacoronavirus / Hidroxicloroquina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos